Mark Arndt
MD
Associate Professor of Pediatrics
👥Biography 个人简介
Mark Arndt specializes in pediatric osteosarcoma treatment and contributes to cooperative group trials through the Children's Oncology Group (COG) evaluating MAP (methotrexate, doxorubicin/Adriamycin, cisplatin) based regimens. His research investigates response assessment after neoadjuvant chemotherapy, surgical planning for limb salvage, and novel agents for poor histological responders. He has contributed to understanding osteosarcoma outcomes in pediatric vs. adult populations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Mark Arndt 的研究动态
Follow Mark Arndt's research updates
留下邮箱，当我们发布与 Mark Arndt（Medical College of Wisconsin / Children's Wisconsin）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment